ClearBridge Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,000
| Closed | -$14K | – | 1199 |
|
|
2018
Q3 | $14K | Hold |
4,000
| – | – | ﹤0.01% | 1038 |
|
|
2018
Q2 | $15K | Sell |
4,000
-269
| -6% | -$1.01K | ﹤0.01% | 1003 |
|
|
2018
Q1 | $17K | Hold |
4,269
| – | – | ﹤0.01% | 993 |
|
|
2017
Q4 | $20K | Sell |
4,269
-4,366
| -51% | -$20.5K | ﹤0.01% | 999 |
|
|
2017
Q3 | $61K | Buy |
8,635
+517
| +6% | +$3.65K | ﹤0.01% | 822 |
|
|
2017
Q2 | $59K | Buy |
8,118
+799
| +11% | +$5.81K | ﹤0.01% | 827 |
|
|
2017
Q1 | $45K | Buy |
7,319
+3,319
| +83% | +$20.4K | ﹤0.01% | 884 |
|
|
2016
Q4 | $23K | Sell |
4,000
-1,000
| -20% | -$5.75K | ﹤0.01% | 953 |
|
|
2016
Q3 | $27K | Sell |
5,000
-1,500
| -23% | -$8.1K | ﹤0.01% | 910 |
|
|
2016
Q2 | $43K | Hold |
6,500
| – | – | ﹤0.01% | 878 |
|
|
2016
Q1 | $30K | Sell |
6,500
-3,501
| -35% | -$16.2K | ﹤0.01% | 914 |
|
|
2015
Q4 | $51K | Sell |
10,001
-1,000
| -9% | -$5.1K | ﹤0.01% | 917 |
|
|
2015
Q3 | $39K | Sell |
11,001
-205,944
| -95% | -$730K | ﹤0.01% | 984 |
|
|
2015
Q2 | $2.17M | Sell |
216,945
-1,469
| -0.7% | -$14.7K | ﹤0.01% | 661 |
|
|
2015
Q1 | $2.78M | Buy |
218,414
+64,740
| +42% | +$824K | ﹤0.01% | 659 |
|
|
2014
Q4 | $2.17M | Sell |
153,674
-4
| -0% | -$57 | ﹤0.01% | 697 |
|
|
2014
Q3 | $2.11M | Sell |
153,678
-89,059
| -37% | -$1.22M | ﹤0.01% | 701 |
|
|
2014
Q2 | $3.73M | Buy |
242,737
+117,691
| +94% | +$1.81M | ﹤0.01% | 627 |
|
|
2014
Q1 | $2.13M | Buy |
+125,046
| New | +$2.13M | ﹤0.01% | 671 |
|